Definitive Healthcare (NASDAQ:DH) Price Target Raised to $3.40 at The Goldman Sachs Group

Definitive Healthcare (NASDAQ:DH - Get Free Report) had its target price increased by equities researchers at The Goldman Sachs Group from $3.00 to $3.40 in a research report issued to clients and investors on Monday,Benzinga reports. The firm presently has a "neutral" rating on the stock. The Goldman Sachs Group's price objective suggests a potential downside of 4.09% from the company's current price.

A number of other equities research analysts also recently issued reports on the stock. Needham & Company LLC reissued a "hold" rating on shares of Definitive Healthcare in a report on Thursday, January 16th. BTIG Research downgraded Definitive Healthcare from a "buy" rating to a "neutral" rating in a research note on Friday. Finally, Barclays reduced their price target on shares of Definitive Healthcare from $4.00 to $3.00 and set an "underweight" rating for the company in a research report on Monday, March 3rd. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $5.10.

Definitive Healthcare Stock Down 3.9%

Shares of DH stock traded down $0.15 during trading hours on Monday, hitting $3.55. 501,295 shares of the company were exchanged, compared to its average volume of 830,642. The company has a market capitalization of $382.73 million, a PE ratio of -1.15, a PEG ratio of 4.06 and a beta of 1.48. Definitive Healthcare has a 52 week low of $2.15 and a 52 week high of $6.27. The business has a 50 day moving average of $2.71 and a two-hundred day moving average of $3.87. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $0.05 EPS for the quarter, beating the consensus estimate of $0.02 by $0.03. The firm had revenue of $59.19 million for the quarter, compared to analyst estimates of $56.20 million. Definitive Healthcare had a negative net margin of 142.38% and a positive return on equity of 1.76%. The business's quarterly revenue was down 6.8% compared to the same quarter last year. During the same period last year, the firm earned $0.08 EPS. Analysts anticipate that Definitive Healthcare will post 0.16 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of DH. Irenic Capital Management LP increased its holdings in Definitive Healthcare by 9.2% in the fourth quarter. Irenic Capital Management LP now owns 7,003,194 shares of the company's stock valued at $28,783,000 after buying an additional 590,009 shares in the last quarter. Palisade Capital Management LP boosted its holdings in shares of Definitive Healthcare by 1.3% in the 1st quarter. Palisade Capital Management LP now owns 2,265,198 shares of the company's stock valued at $6,546,000 after buying an additional 29,774 shares during the period. Dimensional Fund Advisors LP raised its position in shares of Definitive Healthcare by 1.3% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,863,912 shares of the company's stock worth $7,661,000 after buying an additional 23,410 shares in the last quarter. Geode Capital Management LLC raised its holdings in shares of Definitive Healthcare by 3.2% during the fourth quarter. Geode Capital Management LLC now owns 1,272,660 shares of the company's stock valued at $5,231,000 after acquiring an additional 39,938 shares during the period. Finally, New York State Common Retirement Fund grew its position in Definitive Healthcare by 3.2% in the fourth quarter. New York State Common Retirement Fund now owns 771,792 shares of the company's stock worth $3,172,000 after acquiring an additional 23,815 shares in the last quarter. Institutional investors and hedge funds own 98.67% of the company's stock.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.